Literature DB >> 19667398

Dynamic behavior of NK cells during activation in lymph nodes.

Hélène Beuneu1, Jacques Deguine, Béatrice Breart, Ofer Mandelboim, James P Di Santo, Philippe Bousso.   

Abstract

During infection, Toll-like receptor agonists induce natural killer (NK)-cell activation by stimulating dendritic cells (DCs) to produce cytokines and transpresent IL-15 to NK cells. Yet the cellular dynamics underlying NK-cell activation by DCs in secondary lymphoid organs are largely unknown. Here, we have visualized NK-cell activation using mice in which NK cells and DCs express different fluorescent proteins. In response to poly I:C or lipopolysaccharide, NK cells maintained a vigorous migratory behavior, establishing multiple short contacts with maturing DCs. Furthermore, mature antigen-loaded DCs that made long-lived interactions with T cells formed short-lived contacts with NK cells. The different behaviors of T cells and NK cells during activation was correlated with distinct calcium responses upon interaction with DCs. That NK cells become activated while remaining motile may constitute an efficient strategy for sampling local concentrations of cytokines around DCs in secondary lymphoid tissues.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19667398     DOI: 10.1182/blood-2009-06-228759

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  39 in total

Review 1.  Dynamic imaging of host-pathogen interactions in vivo.

Authors:  Janine L Coombes; Ellen A Robey
Journal:  Nat Rev Immunol       Date:  2010-04-16       Impact factor: 53.106

Review 2.  Mechanisms of NK cell activation: CD4(+) T cells enter the scene.

Authors:  Franck Bihl; Claire Germain; Carmelo Luci; Veronique M Braud
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 3.  Natural killer cell activation by dendritic cells: balancing inhibitory and activating signals.

Authors:  Rosa Barreira da Silva; Christian Münz
Journal:  Cell Mol Life Sci       Date:  2011-08-23       Impact factor: 9.261

Review 4.  Dynamics of the interaction of γδ T cells with their neighbors in vivo.

Authors:  Immo Prinz
Journal:  Cell Mol Life Sci       Date:  2011-05-17       Impact factor: 9.261

5.  Automated profiling of individual cell-cell interactions from high-throughput time-lapse imaging microscopy in nanowell grids (TIMING).

Authors:  Amine Merouane; Nicolas Rey-Villamizar; Yanbin Lu; Ivan Liadi; Gabrielle Romain; Jennifer Lu; Harjeet Singh; Laurence J N Cooper; Navin Varadarajan; Badrinath Roysam
Journal:  Bioinformatics       Date:  2015-06-09       Impact factor: 6.937

6.  IL-15.IL-15Rα complex shedding following trans-presentation is essential for the survival of IL-15 responding NK and T cells.

Authors:  Fella Tamzalit; Isabelle Barbieux; Ariane Plet; Julie Heim; Steven Nedellec; Sébastien Morisseau; Yannick Jacques; Erwan Mortier
Journal:  Proc Natl Acad Sci U S A       Date:  2014-05-27       Impact factor: 11.205

7.  The host environment is responsible for aging-related functional NK cell deficiency.

Authors:  Bo-Chin Chiu; Brian E Martin; Valerie R Stolberg; Stephen W Chensue
Journal:  J Immunol       Date:  2013-09-20       Impact factor: 5.422

8.  Infection-induced regulation of natural killer cells by macrophages and collagen at the lymph node subcapsular sinus.

Authors:  Janine L Coombes; Seong-Ji Han; Nico van Rooijen; David H Raulet; Ellen A Robey
Journal:  Cell Rep       Date:  2012-07-05       Impact factor: 9.423

9.  PTEN regulates natural killer cell trafficking in vivo.

Authors:  Jeffrey W Leong; Stephanie E Schneider; Ryan P Sullivan; Bijal A Parikh; Bryan A Anthony; Anvita Singh; Brea A Jewell; Timothy Schappe; Julia A Wagner; Daniel C Link; Wayne M Yokoyama; Todd A Fehniger
Journal:  Proc Natl Acad Sci U S A       Date:  2015-02-02       Impact factor: 11.205

10.  (19)F-MRI for monitoring human NK cells in vivo.

Authors:  Myriam N Bouchlaka; Kai D Ludwig; Jeremy W Gordon; Matthew P Kutz; Bryan P Bednarz; Sean B Fain; Christian M Capitini
Journal:  Oncoimmunology       Date:  2016-02-18       Impact factor: 8.110

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.